How to Get Soolantra Online in Frankfurt

If you are looking to get Soolantra online in Frankfurt, you need a safe, doctor-led clinical evaluation without waiting months for a dermatologist appointment. While Soolantra is a single-agent ivermectin 1% cream, Hi-Doctor does not prescribe standalone Soolantra. Instead, EU-licensed doctors assess your skin through an asynchronous medical questionnaire and may prescribe targeted alternatives, such as a compounded papulopustular rosacea gel containing ivermectin 1%, metronidazole 0.75%, and niacinamide 2%. The entire consultation costs a 40 € one-off fee, doctors review within 24 hours and issue a prescription when clinically appropriate, and your digital prescription can be presented at any EU pharmacy.

Clinical Note: Hi-Doctor does not prescribe brand-name Soolantra monotherapy. EU doctors evaluate cases for targeted compounded formulations containing ivermectin 1% combined with anti-inflammatory actives.

Key Takeaways

• 40 € one-off consultation: The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
• Asynchronous online process: Complete a secure questionnaire with high-resolution photo uploads from home in Frankfurt—no video call required.
• Fast medical assessment: A doctor reviews within 24 hours and issues a prescription when clinically appropriate.
• EU cross-border prescription: Download an official REMPE electronic prescription PDF, which can be presented at any EU pharmacy where the pharmacist may dispense a locally marketed equivalent.

How it works — get your consultation in 4 steps

Acquiring an evaluation for inflammatory rosacea in Frankfurt does not require sitting in a local waiting room. Hi-Doctor provides a structured, asynchronous pathway designed by clinical specialists.

1. Complete the medical questionnaire: Answer questions regarding your symptoms, previous treatments, known triggers, and medical history.
2. Upload clear photographs: Provide sharp, well-lit photos of the affected facial areas so the reviewing doctor can evaluate lesion density and erythema subtype.
3. Clinical evaluation: An EU-licensed doctor assesses your case within 24 hours to determine if a topical prescription is medically appropriate.
4. Receive your electronic prescription: If approved, download your official REMPE prescription PDF directly from your patient portal to present at your local pharmacy in Frankfurt.

Who qualifies

Telemedicine dermatology consultations are suitable for adult patients managing mild to moderate papulopustular rosacea or persistent central facial erythema. Because treatment is strictly topical, certain complex or severe presentations are out of scope.

• Eligible: Adults with central facial redness, inflammatory bumps (papules), or surface pustules seeking topical therapies such as azelaic acid 15% gel or compounded ivermectin-metronidazole-niacinamide formulations.
• Ineligible / Referred to in-person care: Ocular rosacea involving the eyes, phymatous changes (such as rhinophyma), and severe, nodular, cystic, or scarring presentations requiring oral isotretinoin or oral antibiotics.
• Interventions requiring clinics: Vascular laser or intense pulsed light (IPL) therapy for visible telangiectasia must be performed in person.

What Soolantra actually does

Soolantra contains 1% ivermectin. Its primary mechanism of action targets two key drivers of papulopustular rosacea: reducing the overproliferation of microscopic Demodex folliculorum mites residing in hair follicles, and downregulating pro-inflammatory cytokines in the skin barrier.

Hi-Doctor's affiliated doctors frequently prefer a multi-action compounded gel (ivermectin 1% + metronidazole 0.75% + niacinamide 2%) rather than standalone ivermectin. Combining metronidazole's antimicrobial and antioxidant activity with niacinamide's barrier-restorative properties helps soothe erythema while tackling mite density simultaneously. Rosacea is a chronic condition that is controlled rather than cured; clinical improvement typically unfolds over 8 to 12 weeks of consistent application.

Treatment Type	Active Ingredients	Primary Clinical Target	Available via Hi-Doctor
Soolantra (Brand monotherapy)	Ivermectin 1%	Demodex mites & inflammation	No (Brand not prescribed)
Compounded Papulopustular Gel	Ivermectin 1% + Metronidazole 0.75% + Niacinamide 2%	Demodex, inflammatory lesions & barrier support	Yes (Subject to doctor review)
First-Line Monotherapy Gel	Azelaic Acid 15%	Follicular hyperkeratosis & redness	Yes (Subject to doctor review)
Compounded Erythema Cream	Metronidazole 0.75% + Niacinamide 4% + Azelaic Acid 10% + Allantoin 0.5%	Persistent background erythema	Yes (Subject to doctor review)

Side effects and when to stop

Topical rosacea treatments are generally well-tolerated, but localized skin reactions can occur during the initial weeks of treatment. Common mild reactions include transient stinging, burning sensations, dryness, and minor skin irritation.

Discontinue application and seek immediate in-person medical care if you experience severe allergic reactions, marked contact dermatitis, severe facial swelling, or if eye irritation develops. Management of rosacea also requires lifestyle moderation: ultraviolet light exposure, alcohol, extreme heat, spicy foods, and emotional stress are primary triggers that must be managed alongside topical therapy.

Why Hi-Doctor vs. walking into a clinic

Securing a dermatology consultation in Frankfurt can involve waiting weeks or months for an appointment. Hi-Doctor provides a direct, fully GDPR-compliant alternative for adult rosacea patients across Germany.

• No waiting rooms: Submit your details at any time of day via the structured online questionnaire.
• Doctor-governed review: An EU-licensed physician evaluates your skin photos and clinical answers directly.
• Transparent pricing: Flat 40 € one-off consultation fee for dermatology. If the doctor determines that treatment is not clinically appropriate, the 40 EUR consultation fee is refunded in full.
• Standardized EU cross-border format: Prescriptions are issued using the REMPE electronic prescription standard under Directive 2011/24/EU and Commission Implementing Directive 2012/52/EU, containing all mandatory cross-border identification elements.